Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EBS | IVA | CTKB | ||
| Company | Emergent Biosolutions | Inventiva S.A. ADR | Cytek Biosciences Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 12.34 | 4.56 | 5.07 | ||
| High | 12.51 | 4.64 | 5.10 | ||
| Low | 12.02 | 4.55 | 4.95 | ||
| Latest | 12.22 | 4.55 | 5.05 | ||
| Change | -0.21 | +0.07 | -0.05 | ||
| % Change | -1.69% | +1.56% | -0.98% | ||
| Volume | 567,024 | 86,300 | 526,900 | ||
| 20-Day Average Volume | 829,505 | 224,215 | 1,230,550 | ||
| Previous Close | 12.43 | 4.48 | 5.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.97 | 4.36 | 5.00 | ||
| 20-Day Raw Stochastic | 68.57% | 78.08% | 46.67% | ||
| 20-Day Relative Strength | 57.81 | 51.89 | 53.56 | ||
| Weighted Alpha | +14.24 | +104.06 | -5.36 | ||
| Today's Opinion | 100% Buy | 40% Buy | 96% Buy | ||
| Previous Opinion | 100% Buy | 32% Buy | 96% Buy | ||
| Last Month's Opinion | 96% Buy | 32% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.61% since 12/19/25 | +8.08% since 12/19/25 | +2.02% since 12/19/25 | ||
| Low | 12.02 on 12/29/25 | 4.24 on 12/22/25 | 4.95 on 12/29/25 | ||
| High | 12.95 on 12/22/25 | 4.64 on 12/29/25 | 5.18 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | +9.40% since 11/28/25 | +7.06% since 11/28/25 | -10.62% since 11/28/25 | ||
| Low | 10.63 on 12/02/25 | 3.98 on 12/03/25 | 4.56 on 12/16/25 | ||
| High | 12.95 on 12/22/25 | 4.71 on 12/16/25 | 5.61 on 12/01/25 | ||
| 3-Month | |||||
| %Chg | +36.69% since 09/29/25 | -22.49% since 09/29/25 | +49.41% since 09/29/25 | ||
| Low | 8.58 on 10/01/25 | 3.55 on 11/13/25 | 3.35 on 09/30/25 | ||
| High | 13.41 on 10/30/25 | 7.98 on 10/28/25 | 6.18 on 11/17/25 | ||
| 6-Month | |||||
| %Chg | +92.44% since 06/27/25 | +49.18% since 06/27/25 | +42.25% since 06/27/25 | ||
| Low | 5.61 on 08/04/25 | 2.85 on 07/25/25 | 3.09 on 07/22/25 | ||
| High | 13.41 on 10/30/25 | 7.98 on 10/28/25 | 6.18 on 11/17/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 652,824 | 653,861 | 652,111 | ||
| Shares Outstanding, K | 52,520 | 145,951 | 127,865 | ||
| Annual Sales | 1,043,600,000 | 15,930,000 | 200,450,000 | ||
| Annual Net Income | -190,600,000 | -199,340,000 | -6,020,000 | ||
| Last Quarter Sales | 231,100,000 | 65,000 | 52,290,000 | ||
| Last Quarter Net Income | 51,200,000 | -14,296,000 | -5,480,000 | ||
| 60-Month Beta | 2.32 | 0.74 | 1.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.06 on 10/29/25 | N/A on 09/20/21 | -0.01 on 11/05/25 | ||
| Latest Earnings Date | 03/02/26 | 01/01/70 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 6.38 | 0.00 | 0.00 | ||